查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1416700

肝癌診斷市場報告：2030 年趨勢、預測與競爭分析

Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

肝癌診斷趨勢與預測

預計到 2030 年，全球肝癌診斷市場將達到 110 億美元，2024 年至 2030 年年複合成長率為 6.2%。該市場的主要促進因素是肝癌相關發病率的增加以及對快速篩檢方法和就地檢驗的需求不斷增加。全球肝癌診斷市場的未來前景廣闊，醫院和診斷實驗室、學術研究機構、製藥和 CRO 實驗室市場都充滿機會。

肝癌診斷市場洞察

Lucintel 預測，由於實驗室檢測的準確性和成本效益，公眾越來越偏好實驗室篩檢，因此實驗室篩檢將在整個預測期內繼續成為最大的細分市場。

在這個市場中，醫院和診斷實驗室在整個預測期內仍將是最大的部分。

由於健康的醫療保健環境、人們擴大採用醫療保險以及該地區主要企業的存在，預計北美在預測期內將出現最高的成長。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球肝癌診斷市場預計將達到 110 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球肝癌診斷市場預計將以6.2%的年複合成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是肝癌相關發生率的增加以及對快速篩檢方法和就地檢驗的需求不斷增加。

Q4.市場的主要細分市場是：

A4. 肝癌診斷市場的未來前景廣闊，醫院和診斷實驗室、學術研究機構、製藥和 CRO 實驗室市場都有機會。

Q5.市場的主要企業是：

A5. 主要肝癌診斷公司如下。

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific
  • Siemens Healthineers

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於實驗室檢測的準確性和成本效益，公眾越來越偏好實驗室篩檢，因此實驗室篩檢將在整個預測期內繼續成為最大的細分市場。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於擁有強大的醫療保健環境、人們擴大採用醫療保險以及該地區主要企業的存在，預計北美地區將在預測期內實現最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球肝癌診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球肝癌診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 按測試類型分類的全球肝癌診斷市場
    • 臨床檢查
    • 診斷影像
    • 內視鏡檢查
    • 切片檢查
    • 其他
  • 按最終用途分類的全球肝癌診斷市場
    • 醫院和診斷實驗室
    • 學術研究所
    • 製藥與CRO研究所

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球肝癌診斷市場（按地區）
  • 北美洲肝癌診斷市場
  • 歐洲肝癌診斷市場
  • 亞太肝癌診斷市場
  • 其他地區肝癌診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按測試類型分類的全球肝癌診斷市場成長機會
    • 按最終用途分類的全球肝癌診斷市場成長機會
    • 全球肝癌診斷市場按地區成長機會
  • 全球肝癌診斷市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球肝癌診斷市場的產能
    • 全球肝癌診斷市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific
  • Siemens Healthineers
簡介目錄

Liver Cancer Diagnostic Trends and Forecast

The future of the global liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets. The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.

A more than 150-page report is developed to help in your business decisions.

Liver Cancer Diagnostic by Segment

The study includes a forecast for the global liver cancer diagnostic by test type, end use, and region.

Liver Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Laboratory Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others

Liver Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & CRO Laboratories

Liver Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Liver Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver cancer diagnostic companies profiled in this report include-

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific
  • Siemens Healthineers

Liver Cancer Diagnostic Market Insights

Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.

Within this market, hospitaland diagnostic laboratory will remain the largest segment over the forecast period.

North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.

Features of the Global Liver Cancer Diagnostic Market

Market Size Estimates: Liver cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Liver cancer diagnostic market size by test type, end use, and region in terms of value ($B).

Regional Analysis: Liver cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, end uses, and regions for the liver cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the liver cancer diagnostic market size?

Answer: The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030.

Q2. What is the growth forecast for liver cancer diagnostic market?

Answer: The global liver cancer diagnostic market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the liver cancer diagnostic market?

Answer: The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.

Q4. What are the major segments for liver cancer diagnostic market?

Answer: The future of the liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets.

Q5. Who are the key liver cancer diagnostic market companies?

Answer: Some of the key liver cancer diagnostic companies are as follows:

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific
  • Siemens Healthineers

Q6. Which liver cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.

Q7. In liver cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the liver cancer diagnostic market by test type (laboratory tests, imaging, endoscopy, biopsy, and others), end use (hospitals & diagnostic laboratories, academic & research institutes, and pharmaceutical & CRO laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Liver Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Liver Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Liver Cancer Diagnostic Market by Test Type
    • 3.3.1: Laboratory Tests
    • 3.3.2: Imaging
    • 3.3.3: Endoscopy
    • 3.3.4: Biopsy
    • 3.3.5: Others
  • 3.4: Global Liver Cancer Diagnostic Market by End Use
    • 3.4.1: Hospitals & Diagnostic Laboratories
    • 3.4.2: Academic & Research Institutes
    • 3.4.3: Pharmaceutical & CRO Laboratories

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Liver Cancer Diagnostic Market by Region
  • 4.2: North American Liver Cancer Diagnostic Market
    • 4.2.2: North American Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
  • 4.3: European Liver Cancer Diagnostic Market
    • 4.3.1: European Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
    • 4.3.2: European Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
  • 4.4: APAC Liver Cancer Diagnostic Market
    • 4.4.1: APAC Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
    • 4.4.2: APAC Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
  • 4.5: ROW Liver Cancer Diagnostic Market
    • 4.5.1: ROW Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
    • 4.5.2: ROW Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Liver Cancer Diagnostic Market by Test Type
    • 6.1.2: Growth Opportunities for the Global Liver Cancer Diagnostic Market by End Use
    • 6.1.3: Growth Opportunities for the Global Liver Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Liver Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Liver Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Liver Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Qiagen
  • 7.4: Thermo Fisher Scientific
  • 7.5: Siemens Healthineers